News and PR - Optellum

Read more about the article AtlantiCare First in Northeast to Deploy Optellum AI Alongside Robotics for Early Lung Cancer Diagnosis and Treatment

By adopting the Optellum Virtual Nodule Clinic, the Interventional Pulmonology team at AtlantiCare’s Lung Nodule Clinic, led by Amit Borah, M.D., interventional pulmonologist, focuses on identifying and systematically following up on patients with incidentally detected lung nodules.

AtlantiCare First in Northeast to Deploy Optellum AI Alongside Robotics for Early Lung Cancer Diagnosis and Treatment

Post published:February 23, 2023
Post category:News and PR Media Partners

AtlantiCare joined leading healthcare systems worldwide by becoming the first system in the northeastern U.S. to use the Optellum Virtual Nodule Clinic. EGG HARBOR TOWNSHIP, N.J., Feb. 23, 2023 /PRNewswire/ -- AtlantiCare is the…

Jason Pesterfield at the Texas Medical Center

Jason Pesterfield, Optellum CEO, appears on Houston Innovators podcast

Post published:December 23, 2022
Post category:Podcast News and PR

Jason joined the Natalie Harms, the editor of Innovation Map, to talk about Optellum's journey and his career as a serial innovator with roles at Stryker and Veran. "I'm not…

Read more about the article Lung Cancer Awareness Month: Optellum’s AI platform demonstrates a vital role in efficient diagnosis to improve lung cancer survival rates

Lung Cancer Awareness Month: Optellum’s AI platform demonstrates a vital role in efficient diagnosis to improve lung cancer survival rates

Post published:November 17, 2022
Post category:News and PR Event

Lung cancer is the leading cause of cancer deaths worldwide, with approximately 1.8 million people dying from lung cancer each year. The majority of patients are diagnosed after symptoms have…

Read more about the article Optellum, AI Lung Cancer Diagnosis Innovator,<br>Secures $14M Series A Funding to Accelerate Expansion

Optellum, AI Lung Cancer Diagnosis Innovator,
Secures $14M Series A Funding to Accelerate Expansion

Post published:September 27, 2022
Post category:Investment Media News and PR

Lead investor Mercia, alongside Intuitive Ventures and Black Opal, invests inOptellum’s pioneering AI-powered lung-health technology Oxford, 27 September 2022, 8am: Optellum, an Oxford-based medtech company that provides a breakthrough AI…

World lung cancer day badge

How Optellum is working to change the survival rates for lung cancer with an innovative AI platform

Post published:August 1, 2022
Post category:News and PR

Optellum was founded with the vision of providing clinical decision support software that could help lung disease patients be diagnosed and treated with curative intent at the earliest possible stage.…

PRESS RELEASE: CMS assigns new technology payment classification for Optellum’s Lung Cancer Prediction score

Post published:June 28, 2022
Post category:Media News and PR Regulatory

This payment assignment to a newly available Healthcare Common Procedure Coding System (HCPCS) code constitutes an important step towards reimbursing providers for the use of Optellum’s transformative technology with Medicare…

Read more about the article Optellum’s UK regulatory certification bolstered by UKCA marking for its early lung cancer diagnosis AI technology

Optellum’s UK regulatory certification bolstered by UKCA marking for its early lung cancer diagnosis AI technology

Post published:June 16, 2022
Post category:Regulatory News and PR

After gaining CE certification for its software Virtual Nodule Clinic, Optellum has attained UKCA certification under the UK’s Medical Devices Regulations. Optellum, an Oxford-based medtech company, provides breakthrough AI technologies…

PRESS RELEASE: Optellum attains CE marking for its early lung cancer diagnosis AI technology

Post published:March 31, 2022
Post category:Clinical Media News and PR

Optellum Virtual Nodule Clinic, including its proprietary artificial intelligence lung cancer prediction solution, has achieved CE certification under the European Union’s Medical Device Regulation. Oxford, UK – 30 March 2022:…

Read more about the article Optellum recognised by the NHS and Health Education England and included as one of two case studies in AI Roadmap report

Optellum recognised by the NHS and Health Education England and included as one of two case studies in AI Roadmap report

Post published:February 22, 2022
Post category:Clinical News and PR Partners

Optellum is referenced within the report with recommendations on how AI will be implemented and physicians trained in new technologies across the NHS Optellum has been named as one of…

Vanderbilt Lung Institute implements the Optellum Virtual Lung Nodule Clinic

Post published:January 4, 2022
Post category:Clinical News and PR Partners

Vanderbilt University Hospital Medical Center (VUMC) is the first hospital in Tennessee to introduce Optellum's Virtual Nodule Clinic. The world-leading hospital was one of the first to conduct clinical trials…

Read more about the article PRESS RELEASE: GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence

PRESS RELEASE: GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence

Post published:November 26, 2021
Post category:Media News and PR Partners

Oxford, UK/Chalfont St Giles 26 November 2021 13:00 GMT - GE Healthcare and Optellum today announced that they have signed a letter of intent to collaborate to advance precision diagnosis…

Jason Pesterfield at the Texas Medical Center

PRESS RELEASE: Optellum Appoints Jason Pesterfield as CEO to Drive Commercial Growth in the USA

Post published:September 14, 2021
Post category:Latest News Media News and PR Team

Fast-growing lung-health AI startup strengthens executive team with business leader experienced in medical devices for lung cancer diagnosis. Jason Pesterfield was previously CEO at Veran Medical Technologies, growing it through…